Intestinal CYP3A4 protects against lithocholic acid-induced hepatotoxicity in intestine-specific VDR-deficient mice.
about
Transgenic mice and metabolomics for study of hepatic xenobiotic metabolism and toxicityA meta-analysis of association of vitamin D receptor BsmI gene polymorphism with the risk of type 1 diabetes mellitus.The role of vitamin D in reducing gastrointestinal disease risk and assessment of individual dietary intake needs: Focus on genetic and genomic technologies.Metabolic mapping of A3 adenosine receptor agonist MRS5980Irinotecan (CPT-11)-induced elevation of bile acids potentiates suppression of IL-10 expression.Synthesis and evaluation of vitamin D receptor-mediated activities of cholesterol and vitamin D metabolitesPharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules.Association between Circulating Vitamin D Metabolites and Fecal Bile Acid Concentrations.LC-MS-based metabolomics: an update.Effects of supplemental calcium and vitamin D on the APC/β-catenin pathway in the normal colorectal mucosa of colorectal adenoma patients.Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes.Role of the lipid-regulated NF-κB/IL-6/STAT3 axis in alpha-naphthyl isothiocyanate-induced liver injury.Vitamin D, the gut microbiome and inflammatory bowel disease
P2860
Q28087473-79875F3A-60FF-4D8A-A9CC-43DD03ECBF14Q35130503-2AA95FF2-DEF4-471A-92B8-203D092AB0EFQ35739443-D8FB67FC-6F7E-4ECE-BEF3-03DA96EE57E5Q36088970-B19B4FC4-9DE4-4C11-931A-875166471E26Q36479746-21972A74-4AB9-43A7-BB86-C3946274515AQ36535131-3A3E928C-6A06-4CD4-8FDC-66A6F6FA5B1EQ36987335-B6FAC5A0-59AD-4FF9-BE7C-239EB26C2F19Q37194017-93A88F30-8A44-4779-A89F-8696B9BAA53CQ38202881-56AD3F1E-7F9F-413F-9869-0DE57EED972CQ40722581-5C3FEA2F-95C8-4B6F-851B-9718AA8A2C7CQ42700015-9950D4F6-E53D-4872-A65B-B1CE0FB72A06Q51323656-6F2BC23A-8CBC-40DE-85CC-DCF443A25295Q58712273-3E85DAB8-B8D2-4AA5-BCE5-78BC7A224B4F
P2860
Intestinal CYP3A4 protects against lithocholic acid-induced hepatotoxicity in intestine-specific VDR-deficient mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intestinal CYP3A4 protects aga ...... e-specific VDR-deficient mice.
@en
Intestinal CYP3A4 protects aga ...... e-specific VDR-deficient mice.
@nl
type
label
Intestinal CYP3A4 protects aga ...... e-specific VDR-deficient mice.
@en
Intestinal CYP3A4 protects aga ...... e-specific VDR-deficient mice.
@nl
prefLabel
Intestinal CYP3A4 protects aga ...... e-specific VDR-deficient mice.
@en
Intestinal CYP3A4 protects aga ...... e-specific VDR-deficient mice.
@nl
P2093
P2860
P356
P1476
Intestinal CYP3A4 protects aga ...... ne-specific VDR-deficient mice
@en
P2093
Frank J Gonzalez
Kristopher W Krausz
Naoki Tanaka
Zhong-Ze Fang
P2860
P304
P356
10.1194/JLR.M044420
P577
2013-12-16T00:00:00Z